BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23328585)

  • 1. Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model.
    Bachawal SV; Jensen KC; Lutz AM; Gambhir SS; Tranquart F; Tian L; Willmann JK
    Cancer Res; 2013 Mar; 73(6):1689-98. PubMed ID: 23328585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
    Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
    Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
    Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
    Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric spectroscopic photoacoustic imaging of breast cancer development in a transgenic mouse model.
    Wilson KE; Bachawal SV; Tian L; Willmann JK
    Theranostics; 2014; 4(11):1062-71. PubMed ID: 25285161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
    Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
    Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.
    Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC
    J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection.
    Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK
    Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
    Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
    Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55).
    Bzyl J; Palmowski M; Rix A; Arns S; Hyvelin JM; Pochon S; Ehling J; Schrading S; Kiessling F; Lederle W
    Eur Radiol; 2013 Feb; 23(2):468-75. PubMed ID: 22878592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging.
    Bam R; Natarajan A; Tabesh F; Paulmurugan R; Dahl JJ
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).
    Bzyl J; Lederle W; Rix A; Grouls C; Tardy I; Pochon S; Siepmann M; Penzkofer T; Schneider M; Kiessling F; Palmowski M
    Eur Radiol; 2011 Sep; 21(9):1988-95. PubMed ID: 21562807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
    Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
    Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.
    Bam R; Lown PS; Stern LA; Sharma K; Wilson KE; Bean GR; Lutz AM; Paulmurugan R; Hackel BJ; Dahl J; Abou-Elkacem L
    Clin Cancer Res; 2020 May; 26(9):2140-2150. PubMed ID: 31924738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.
    Bachawal SV; Jensen KC; Wilson KE; Tian L; Lutz AM; Willmann JK
    Cancer Res; 2015 Jun; 75(12):2501-9. PubMed ID: 25899053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.
    Deshpande N; Ren Y; Foygel K; Rosenberg J; Willmann JK
    Radiology; 2011 Mar; 258(3):804-11. PubMed ID: 21339349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography.
    Lyshchik A; Fleischer AC; Huamani J; Hallahan DE; Brissova M; Gore JC
    J Ultrasound Med; 2007 Nov; 26(11):1575-86. PubMed ID: 17957052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Resection Guidance with Photoacoustic and Fluorescence Molecular Imaging Using an Anti-B7-H3 Antibody-Indocyanine Green Dual Contrast Agent.
    Wilson KE; Bachawal SV; Willmann JK
    Clin Cancer Res; 2018 Aug; 24(15):3572-3582. PubMed ID: 29712688
    [No Abstract]   [Full Text] [Related]  

  • 18. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
    Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
    Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added Value of Breast MRI for Preoperative Diagnosis of Ductal Carcinoma In Situ: Diagnostic Performance on 362 Patients.
    Petrillo A; Fusco R; Petrillo M; Triunfo F; Filice S; Vallone P; Setola SV; Rubulotta M; Di Bonito M; Rinaldo M; D'Aiuto M; Brunetti A
    Clin Breast Cancer; 2017 Jun; 17(3):e127-e134. PubMed ID: 28111130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).
    Pysz MA; Foygel K; Rosenberg J; Gambhir SS; Schneider M; Willmann JK
    Radiology; 2010 Aug; 256(2):519-27. PubMed ID: 20515975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.